Biliary tract cancer patient-derived xenografts: Surgeon impact on individualized medicine.
JHEP Rep
; 2(2): 100068, 2020 Apr.
Article
em En
| MEDLINE
| ID: mdl-32181445
CCA, cholangiocarcinoma; ECM, extracellular matrix; GBCA, gallbladder carcinoma; HRs, hazard ratios; LOH, loss of heterozygosity; MatePair sequencing; OPTR, overall patient take rate; OS, overall survival; PDX, patient-derived xenograft; Patient-derived xenografts; TTF, time to tumor formation; TTH, time to tumor harvest; biliary tract; cholangiocarcinoma; dCCA, distal cholangiocarcinoma; gallbladder carcinoma; iCCA, intrahepatic cholangiocarcinoma; pCCA, perihilar cholangiocarcinoma
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Tipo de estudo:
Prognostic_studies
Idioma:
En
Revista:
JHEP Rep
Ano de publicação:
2020
Tipo de documento:
Article
País de afiliação:
Mongólia